Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Academic Radiology|July 8, 2010
Detection of aortic regurgitation with 64-slice multidetector computed tomography (MDCT)Irfan Zeb, Yasmin S Hamirani, Songshuo Mao, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 19, 2022
Sixteen-Year National Trends in Use and Outcomes of VA-ECMO in Cardiogenic ShockMoinuddin Syed, Muhammad Zia Khan, Mohammed Osman, et al.
International Journal of Cardiology|November 27, 2016
Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategyRamez Nairooz, Marco Valgimigli, Yogita Rochlani, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 14, 2017
Comparison of the prognostic value of non-ischaemic fractional flow reserve using intracoronary versus intravenous adenosineNaga Venkata K Pothineni, Mohan M Edupuganti, Ahmed Almomani, et al.
American Journal of Cardiovascular Disease|May 20, 2024
Procedural and cardiovascular outcomes of geriatric vs non-geriatric patients undergoing permanent pacemaker implantation - a nationwide cohort analysisAyesha Shaik, Madhuwani Rojulpote, Nicholas Roma, et al.
Korean Circulation Journal|October 26, 2023
Trends and Outcomes of Type 2 Myocardial Infarction During the COVID-19 Pandemic in the United StatesHarshith Thyagaturu, Nicholas Roma, Aakash Angirekula, et al.
The Journal of Invasive Cardiology|April 20, 2017
Clinical Decision-Making for the Hemodynamic "Gray Zone" (FFR 0.75-0.80) and Long-Term OutcomesShiv Kumar Agarwal, Srikanth Kasula, Mohan M Edupuganti, et al.
Expert Review of Cardiovascular Therapy|December 18, 2023
Trends and cardiovascular outcomes of Takotsubo syndrome with cardiogenic shock vs. mixed cardiogenic and septic shock: a nationwide propensity matched analysisSadaf Fakhra, Mohammed Faisaluddin, Yasar Sattar, et al.
International Journal of Cardiology. Heart & Vasculature|August 7, 2024
Efficacy and safety of Mavacamten for symptomatic Hypertrophic cardiomyopathy - an updated Meta-Analysis of randomized controlled trialsIrfan Ullah, Syeda Tayyaba Rehan, Zayeema Khan, et al.
Pageof 4